LAURA MINIK: Open Payments
NPI 1720742968 · BEAVERCREEK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 29 payments from 13 companies in 2025. Trend: 2023 $134 · 2024 $813 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $166 |
| QOL Medical, LLC | 3 | $73 |
| Janssen Biotech, Inc. | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Ardelyx, Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| GENZYME CORPORATION | 1 | $39 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Celltrion USA Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: DUPIXENT, Sucraid, SKYRIZI, TREMFYA, IBSRELA, LINZESS, RINVOQ, REZDIFFRA.
Industry payments across OH — which companies pay providers there.
